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ABSTRACT
Protein kinase CK2 is a serine/threonine kinase
known to phosphorylate numerous substrates.
CK2 is implicated in several physiologic and
pathologic processes, particularly in cancer biology.
CK2 is comprised of several subunits, including
CK2a, CK2a’ and CK2b. Inactivation of CK2a’ leads
to chromatin degeneration of germ cells, resulting
in male sterility. To identify additional targets of
CK2a’ in testes and to determine the role of CK2a’
in germ cell nuclear integrity, GST pull-down and
protein–protein interaction assays were conducted.
A novel testis-specific gene, CKT2 (CK2 Target
protein 2), was found whose product interacts with
and is phosphorylated by CK2 in vitro and in vivo.
CKT2 is a 30.2kDa protein with one coiled-coil
domain and six putative phosphorylation sites.
High expression of CKT2 correlated with chromatin
condensation of spermatids in murine testes.
Findings reported herein demonstrate that CKT2
is a target protein of native CK2a’ in testes and
suggest that CKT2 plays a role in chromatin regula-
tion of male germ cells.
INTRODUCTION
Protein Kinase CK2 is a serine/threonine phosphotrans-
ferase that exists primarily as a tetrameric structure with
two catalytic subunits, CK2 alpha (CK2a) and CK2 alpha
prime (CK2a0), and two regulatory CK2 beta (CK2b)
subunits (1). CK2a and CK2a0 are gene products of
Csnk2a1 and Csnk2a2, respectively. A third isoform of
the catalytic subunit, called CK2a00, is a larger variant
of CK2a that has a translated Alu sequence at the
C-terminus (2). The human genome contains four CK2
loci, corresponding to three active genes, coding for the
catalytic a and a0 subunits, one regulatory b subunit, and a
processed a subunit pseudogene (3). CK2 has the unique
ability to utilize GTP as a phosphate donor in place
of ATP (4).
CK2 has been reported to phosphorylate many physio-
logical substrates (4). More than one-third of the known
300+ protein substrates phosphorylated by CK2 are
involved in gene expression and protein synthesis, either
as transcription factors, eﬀectors of DNA/RNA
structure, or translation elements. Substrates for CK2
also function as signalling proteins and those essential
for viral replication (5,6). Candidate cellular CK2
substrates include proto-oncogene products such as
c-Myc, c-Myb and c-Jun; tumour-suppressor gene pro-
ducts such as p53 and BRCA1; transcriptional regulators
such as Max, Cut, PU.1/IRF4 and Six1; and components
of the canonical Wnt pathway (7).
CK2 has been implicated in diverse cellular processes
such as cell cycle regulation and cell growth, circadian
rhythms, apoptosis, regulation of cell polarity, embryonic
development, cell morphology and the cytoskeleton
(4,8,9). Increased constitutive activity of CK2 has also
been implicated in the pathogenesis of various infectious
diseases, neurodegenerative diseases and cardiovascular
disorders (10).
The best known pathogenic role for CK2 has been in
neoplastic growth and high CK2 activity has been
observed in numerous cancers (11). Consistent with its
ability to enhance cancer growth, CK2 promotes aberrant
activation of nuclear factor-kappaB, suppression of cellu-
lar apoptosis and survival of breast cancer cells (12,13).
It also induces lymphocyte transformation in transgenic
mice, collaborates with Ha-Ras in ﬁbroblast transforma-
tion, and is involved in the pathobiology of androgen-
dependent and -independent prostate cancer (14,15).
CK2 can exert an anti-apoptotic role by protecting regula-
tory proteins from caspase-mediated degradation and
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cancer-promoting properties, CK2 has been considered
to be a target of anti-neoplastic treatments (16,17).
The catalytic subunits of CK2—CK2a and CK2a0—are
paralog proteins. Typically, the evolution of paralog pro-
teins is associated with a functional specialization (18).
CK2a and CK2a0 exhibit approximately 90% identity
in their catalytic domains, but mainly diﬀer in their
C-terminal region (18). CK2a’ and CK2a are signiﬁcantly
diﬀerent with respect to some well-known CK2 properties
such as autophosphorylation and supra-molecular
aggregation (18). Abundance of CK2a0-containing
holoenzyme in certain tissues suggests an important role
of CK2a0 in these tissues (18,19). Indeed, CK2a is the
more abundant CK2 subunit in developing embryos ad
in contrast to CK2 0 /  embryos, CK2  /  embryos
die in mid-gestation (20). A pro-neoplastic role for
CK2a0 has been demonstrated in that human osteosar-
coma U2-OS cell proliferation is inhibited following the
over-expression of a kinase inactive variant of CK2a0, but
not of CK2a (15).
CK2a0 is found predominantly in testis (21,22). Our
previous studies showed that male mice lacking CK2 0
were infertile and exhibited an abnormal shape in
their spermatid nuclei (23). In addition, a signiﬁcant
number of germ cells in the CK2 0 /  mice were elimi-
nated by apoptosis (23). Moreover, male germ cells
at various steps of diﬀerentiation showed unique
perturbations of chromatin and nuclear envelope in the
CK2 0 /  mice (24). Therefore, the phenotype of the
CK2 0 /  mice suggests that CK2a0 has a role in cell
survival, in maintaining nuclear integrity of male germ
cells, and raises the question of whether dysregulated
expression of CK2a0 may be involved in testicular
malignancy.
Compared to other CK2 subunits, signiﬁcantly less
is known about CK2a0. To better understand the testis-
speciﬁc function of CK2a0, the yeast two-hybrid technique
was used to identify protein(s) that can interact with
testicular CK2a0. As we will show, a new gene designated
CKT2 (CK2 Target protein 2) was identiﬁed in the mouse
chromosome 16 and speciﬁcally expressed in mouse testes.
Furthermore, we will show that CKT2 is a target protein
of CK2a0, is phosphorylated by CK2, and is present in
the nuclei of mouse spermatids during chromatin
condensation.
MATERIALS AND METHODS
Detailed descriptions of the following Materials and
Methods are given in the Supplementary data: reagents
and molecular tools, and Southern blot.
Constructionof plasmids fortwo-hybrid experiments
The ORF region of CK2 0, CK2  and CK2  were cloned
into the Gal4 DNA-binding domain vector pGBKT7.
ORF N- and C-terminal regions of CKT2 were cloned
in Gal4 transcriptional activation domain vector
pACT2; all plasmids were constructed by standard molec-
ular biology methods (25) and conﬁrmed by sequencing.
Yeast two-hybrid screen and cDNA isolation
The full length murine CK2 0 cDNA was cloned into the
pGBKT7 vector in the in-frame fusion of CK2 0 with the
DNA-binding domain of the yeast GAL4 protein. A
mouse testis cDNA library containing 4.5 10
6 indepen-
dent clones (Clontech Laboratories Inc.) was cloned into
pACT2 to produce fusions between the targeted proteins
and the cDNA activation domain of GLA4. Screening
was performed by sequential transformation of bait and
library vectors in Saccharomyces cerevisiae strain Y190
used for the screening assay containing his, ade and lacZ
reporter genes under the control of a GAL4-responsive
upstream activation site. Transformants were plated on
SC-Leu-Trp-Ade-His- medium and incubated at 308C
for up to 3–5 days. A cDNA for the CKT2 gene was
obtained from 2 10
6 transformants of mouse testis
cDNA in pACT2 and using CK2 0 as bait in pGBKT7
clones. A testis cDNA library in  gt11 was screened for
the selected clone 8. For the localization of CKT2 gene,
the mouse BAC genome DNA was used (Clontech
Laboratories Inc.). The DNA sequencing was performed
at Yale University, and the GenBank database was
searched by using the BLAST program (National Center
for Biotechnology Information, Bethesda, MD, USA).
Isolation of RNA and RT–PCR
Total RNA was isolated from diﬀerent organs of adult
mice as described previously (26). RT–PCR using the
Advantage RT–PCR Kit (Promega Corp.) was performed
according to the manufacturer’s instruction. The follow-
ing primers were used: primer of sense mouse  -actin 50-G
CTGTGTTCCCATCCAT-CGTGG-30 (nt1, 875–1896)
and antisense mouse  -actin 50-GACGCATGATGGCG-
GTGTGGCA-30 (nt 2561–2540), CKT2 sense primer 50-C
AATTCCATCTCCAAGTCTAC-30 (nt 451–472) and
CKT2 antisense primer 50-TCAGGATTTCTCATTTTG
AAAC-30 (nt 1339–1317).
Recombinant proteins
To produce the CKT2 and CK2 subunit recombinant pro-
tein, the coding region of CKT2 and CK2 subunit cDNA
was ampliﬁed by PCR using primers representing the ﬁrst,
middle and last 20 nucleotides of CKT2 and CK2. The
upstream and downstream primers contained at their
50-ends a BamHI and EcoRI restriction enzyme recogni-
tion site, respectively. The PCR product was unidirec-
tionally cloned into pGEX2 vector to create pGCKT2
(1–276), pGCKT2-n (1–137) and pGCKT2-c (138–276)
GST fusion vectors. For expression, Escherichia coli
BL21 were used. The cells were ﬁrst grown at 308Ct o
an optical density of 0.8, induced with 0.5mM ﬁnal
concentration of isopropyl-b-D-thiogalactopyranoside
(IPTG), and incubated at 308C for another 5h before har-
vesting the culture. The recombinant protein was puriﬁed
on glutathione-Sepharose
TM 4B (Amersham Biosciences
AB, Uppsala Sweden), and the protein concentration
was determined by the Bradford Protein Assay (Bio-Rad
Laboratories, Hercules, CA, USA).
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The (1–276) and (138–276) CKT2 cDNA were constructed
in pGEX2 vector (Pharmacia). The recombinant proteins
were expressed in Escherichia coli BL21 and puriﬁed
by glutathione-sepharose beads (Pharmacia). The recom-
binant proteins were injected into female mice to produce
monoclonal antisera against CKT2. For polyclonal anti-
bodies, peptides encompassing 83–102 and 257–276 CKT2
amino acids were synthesized; conjugated to KLH and
injected into rabbits. Antisera were puriﬁed by aﬃnity to
CKT2 peptide.
In situ hybridization
Paraﬃn-embedded testicular sections of C57BL/6J adult
male mice were ﬁxed in freshly prepared 4% paraformal-
dehyde in PBS. The cDNA fragment of CKT2 was cloned
into vector pBluescript II KS
+ containing two RNA tran-
scription promoters, T3 and T7, to be named pBCKT2.
The sense probe was synthesized using T3 RNA poly-
merase and the plasmid was linearized with XhoI, whereas
the antisense probe was synthesized using T7 RNA
polymerase and the plasmid was linearized with EcoRI.
In situ hybridization (ISH) was performed using
35S-labeled antisense or sense probes transcribed from
full-length cDNA for CKT2 by using a Superscript kit
(Promega Corp.). Tissue section ISH was performed as
previously described (26).
Immunohistochemistry
Testes were decapsulated, ﬁxed for 3h in 4% paraformal-
dehyde in PBS (phosphate-buﬀered saline) and then
incubated in sucrose solutions of increasing concentration
(12%, 15% and 18%) before freezing and sectioning.
Sections were incubated with anti-CKT2 antibody (diluted
1/100). Controls were performed as for immunoelectron
miscroscopy (see below). Immunohistochemical labeling
was performed with the three-step immunoperoxidase
technique using the biotin-avidin system (Vector Labora-
tories, Burlingame, CA, USA). Amino-ethyl-carbazole
was used as the chromogen. Sections were counterstained
with Harris hematoxylin and mounted in aqueous medium
(Glycergel, Dako Corp., Carpinteria, CA, USA).
Immunoelectron microscopy
Testes from 2- to 3-month-old C57BL/6J mice were ﬁxed
with 4% paraformaldehyde at 48C overnight for post-
embedding immunolabeling. The samples were washed
several times in 1 PBS and subsequently dehydrated
with a series of graded ethanol solutions, then embedded
in Lowicryl K4M and crosslinked under UV for 3 days at
48C. Ultrathin (900nm) sections were dehydrated with
PBT/nonfat milk [PBS, pH 7.2, 0.05% (v/v) Tween 20,
0.1% (w/v) nonfat milk] for 15min and incubated with
anti-CKT2 antibodies for 2hrs, extensively washed with
PBT, and incubated for 1h with secondary IgG antibody
labeled with colloidal gold (15nm gold particles;
BBInternational, Cardiﬀ, UK), both diluted 1/100 in
PBS/nonfat milk. Grids were then washed in PBT and
rinsed in distilled water. Control experiments were
performed by (i) omission of the anti-CKT2 antibodies,
(ii) replacement of anti-CKT2 antibodies by preimmune
serum and (iii) preincubation of CKT2 antibodies
with the speciﬁc CKT2 peptide. Counterstaining was
omitted. The ultrastructural examination of the tissues
was performed using a JEOL (JEM 100CX II) (Jeol
Ldt, Tokyo, Japan) electron microscope operating at 80
Kv, and photographs taken on Kodak electron micros-
copy ﬁlm.
b-galactosidasefilter and liquid assay
Single colonies were picked and transferred to a
Whatman ﬁlter paper (No. 5) for b-galactosidase assay;
the ﬁlter and liquid assay were performed as previously
described (26).
Cellculture andtransfection
HEK293 cells were cultured in Fugene’s medium
(Boheringer Mannheim, Germany) following the com-
pany’s description and supplemented with 10% fetal
bovine serum (Invitrogen, BV NV Leek, Netherlands) at
378C in a 5% CO2 incubator. A Flag tag was fused to
CKT2 and subcloned into pcDNA3 expression vector
(Invitrogen) and the DNA construct was veriﬁed by
direct sequencing. The cells were transfected using the cal-
cium phosphate precipitation method as described pre-
viously (27), using 50mg of DNA per 8 10
6cells in a
15-cm diameter plate. Co-transfection experiments used
equivalent amounts of DNA for each plasmid unless
otherwise indicated. Cells were washed thoroughly with
PBS and replenished with fresh medium at 16–18h
after transfection. After 3 days, the cells were ﬁxed in
2% paraformaldehyde and stained with M2 anti-Flag
antibody (Sigma Aldrich). Following addition of a sec-
ondary anti-mouse IgG antibody coupled to FITC, immu-
noﬂuorescence was detected.
Glutathione S-transferase pull-down assay
GST pull-down assay was performed with puriﬁed GST-
CKT2 fusion protein. Method 1 (GST-CKT2 plus labeled
35S-CK2 0 or
35S-CK2 ): CK2a0 or CK2a subunits
labeled with [
35S] methionine were synthesized by coupled
transcription translation with wheat germ extract from
a TnT kit (Promega Corp.) and with T7 polymerase
according to manufacturer’s instructions. For in vitro
binding, 20ml of the reaction was added to 200ml of bind-
ing buﬀer (100mM KCl, 10% glycerol, 5mM EDTA/
20mM Hepes, pH 7.6, 0.02% NP40, 1mM DTT, 5mg/
ml BSA) followed by 10ml of glutathione-agarose beads
with bound GST or GST-CKT2 and the mixture was
incubated at 48C. The beads were washed three times
with binding buﬀer. Bound proteins were eluted with
2  SDS–PAGE sample buﬀer and were resolved by
12% SDS–PAGE.
35S-labeled bands were detected by
X-ray autoradiography using a PhosphoImager 425
(Molecular Dynamics, Sunnyvale, USA). Method 2
(GST-CKT2 plus testicular lysate):2 0 ml of glutathione-
agarose beads bound to GST-CKT2 or GST were
incubated at 48C with 30ml of testicular lysates from
either the wildtype or CK2 0 null mice. The beads were
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teins were eluted with 2  SDS–PAGE sample buﬀer,
resolved by 12% SDS–PAGE, and the separated proteins
transfered to PVDF membranes (Boehringer, Mannheim,
Germany) in buﬀer containing 20mM Tris–HCl, 150mM
glycine, pH 8.9. The membranes were blocked for 1h
in buﬀer [0.05% (v/v) Tween 20 in PBS pH 7.4] with
5% (w/v) dry milk, washed in PBS and incubated for 1h
with CK2a and CK2a0 antibodies (1:1000 dilution, Santa
Cruz Biotechnology, Santa Cruz, CA, USA). Following
washing in binding buﬀer, the membranes were decorated
with HRP-conjugated secondary antibody, washed
and visualized by ECL according to the manufacturer’s
instructions (Amersham Buschler Gmbh & Co. KG,
Braunschweig, Germany).
Invitro kinase assays
The speciﬁc CK2 inhibitor peptides were ETERRREEE
TEEE and DSDRRRDDDSDDD (Gift from Dr D.C.
Seldin, Boston, MA, USA). CK2 peptide without a phos-
phorylation site (RETSALLRYFQTKFQNEKS) was
used as control. The GST-CKT2 fusion proteins were
expressed in recombinant Escherichia coli and immobi-
lized on glutathione-agarose beads. GST-CKT2 beads
were then incubated with 10mg of protein lysates of
mouse testes (wildtype or CK2 0 mutant) at 48C for 2h,
then washed three times with buﬀer (20mM Tris–HCl at
pH 7.5, 200mM NaCl, 1.5mM MgCl2, 0.2mM EDTA,
1% Triton X-100, 0.1mM dithiothreitol, 1mM PMSF
protease inhibitor). The samples were then incubated
in 400ml buﬀer (100mM Tris, pH 8.0 20mM MgCl2,
100mM NaCl, 50mM KCl and 100mM ATP containing
5mCi of g-
32P-ATP) at 308C for 30min. The kinase reac-
tions were terminated by washing the samples twice and
re-suspending the samples in SDS sample buﬀer. Then
the samples were boiled for 5min and the proteins were
resolved by SDS–PAGE. Phosphorylated proteins were
visualized and quantiﬁed by PhosphoImager analysis.
Immunoprecipitation, western blot analysis and
CK2kinase assay
Immunoprecipitation. Testicular cell extracts of C57BL/6J
mice were prepared by griding mice testicles with a lysis
buﬀer containing phosphatase and protease inhibitors
[50mM Tris–HCl, pH 7.5, containing 0.5% (v/v)
Nonidet P-40, 1mM EDTA, 150mM NaCl; 5mg/ml
aprotinin, 5mg/ml leupeptin, 2mM Na3VO4,1 m M
PMSF]. After centrifuging the lysates at 20800g at 48C
for 15–30min, the protein concentrations were deter-
mined. One hundred mg aliquots of the testicular lysates
were incubated with the anti-CKT2 antibody (2mg/ml)
or the anti-CK2a0 antibody (2mg/ml) overnight at 48C
with gentle rotary mixing. The protein-antibody com-
plexes were isolated by the addition of 20ml protein
A-sepharose beads (Santa Cruz), followed by gentle
rotary mixing for 2h at 48C. The beads were then
washed three times with wash buﬀer [20mM Tris–HCl
at pH 7.5, 200mM NaCl, 1.5mM MgCl2, 0.2mM
EDTA, 1% (v/v) Triton X-100, 1mM DTT, 1mM
PMSF].
Western blot. The bead pellets obtained were resuspended
in 30ml1   Laemlli/DTT buﬀer, incubated for 5min at
958C, and then separated by SDS–PAGE. The separated
proteins were transferred onto PVDF membranes
(Millipore) by electroblotting. The blotted membranes
were blocked with 1 TBS containing 5% (w/v) nonfat
milk and 0.05% (w/v) Tween-20 for 1h at room tem-
perature to reduce any nonspeciﬁc interactions. After
multiple washings with 1 TBS, the membrane was incu-
bated with anti-CK2a0 antibody for 1hr in 1 TBS
containing 5% (w/v) nonfat milk. After additional
washes, the membranes were incubated with HRP-
conjugated secondary antibodies (1:2000) for 60min at
room temperature in 1 TBS containing 5% (w/v)
nonfat milk. After additional washings, the membranes
were developed using an enhanced chemiluminescence
detection kit (Cell Signaling Technology) and XAR
sensitive ﬁlm (Amersham Biosciences).
CK2 kinase assay. The CK2a0 immunoprecipitated pellets
obtained were resuspended in 25ml of kinase buﬀer
(100mM sodium orthovanadate, 100mM Tris–HCl
(pH 8), 100mM sodium chloride, 20mM MgCl2,5 0 m M
KCl, 100mM ATP containing 5mCi of [g-
32P] ATP and
5mg/ml CK2 casein). Kinase reactions were incubated
for 15min at 378C and stopped by the addition of
10ml of reducing solubilizing buﬀer [50mM Tris–HCl,
(pH 6.8), 100mM DTT, 2% (w/v) SDS, 0.1% (w/v)
bromphenol blue, 10% (v/v) glycerol]. Samples were
boiled for 10min and subjected to SDS–PAGE. After
electrophoresis, the gels were ﬁxed for 20min in a solu-
tion containing 40% (v/v) methanol and 10% (v/v) ace-
tic acid. These were washed once with distilled water
before being dried under vacuum and subjected to
autoradiography.
Metabolic labeling
HEK293 cells (500000cells/well in a 6-well tissue culture
plate) were transfected with pcDNA3 or pcDNA3-CKT2
plasmid using Lipofectamine 2000 according to manufac-
turer’s instructions (Invitrogen) and then cultured for
24h. The cells were then washed twice with phosphate-
free DMEM supplemented with 10% heat-inactivated
FBS. The cells were then incubated with 1mCi/ml
[
32P]-orthophosphate in the same medium for 6h (28).
The cells were lysed, centrifuged, and the supernatant of
the cell lysates were immunoprecipitated with 1mg anti-
CKT2 antibody per condition. The immunoprecipitated
CKT2 was separated by SDS–PAGE, transferred to
a nitrocellulose membrane and subjected to autoradiog-
raphy. Total CKT2 was qualitatively determined by
immunoblotting the same membrane with 1:1000 anti-
CKT2 antibody.
RESULTS
Isolation of murineCK2a’interacting partners
To identify proteins that can interact with CK2a0,a
yeast two-hybrid screening was performed using the
GAL4 recognition site to regulate expression of his,
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fusion protein alone did not activate transcription of
the reporter genes (GAL4-DB: GAL4 DNA-binding
domain). The GAL4-DB-CK2a0 plasmid pGBKT7 was
co-transformed with the GAL4-AD-cDNA library of
mouse testis pACT2 into the AH109 strain of S. cerevisiae
(GAL4-AD: GAL4 activation domain). Transformants
were plated on SC-Leu-Trp-Ade-His-selective medium.
Fifteen candidates positive for CK2a0 were obtained
from 2 10
6 yeast cells co-transformed with murine
testicular cDNA library in pACT2 and with CK2a0 in
pGBKT7 plasmid as bait. Sequence analysis showed that
13 of them were CK2 , one was CKT1 (unpublished data),
and one was a new gene designated CKT2, which was
further analyzed.
Characteristics of CKT2
Since a putative translational initiation codon was missing
in this cDNA CKT2 clone, a mouse testis cDNA library in
 gt11 was screened to isolate corresponding clones and
used as a probe. The sequence of the full-length cDNA
was accepted in Genbank (accession number NM_173861;
NCBI interim symbol is Ckt2). Analyses of CKT2 DNA
sequence showed that the ORF of CKT2 encodes a 276
amino acid protein corresponding to a 30.2kDa gene
product (Figure 1A). The ﬁrst start codon (ATG) of the
ORF began at position 511 and was preceded by an
in-frame stop codon at position 21 to 24 and by a
purine (A) at position 3. The deduced amino acid sequence
of CKT2 showed a 23.9% homology with c-Myc
(Supplementary Figure 1). According to the consensus
sequence (S/T)XX(D/E) that is phosphorylated by
CK2, analysis of the CKT2 sequence revealed six putative
CK2 phosphorylation sites (Figure 1A). A stretch of
residues located at position 75-108 exhibited a strong
probability of coiled-coil formation, as conﬁrmed by the
use of the coiled-coil domain prediction program
(www.ch.embnet.org) (Figure 1B).
To localize the CKT2 gene, a Southern blot was
performed with BAC mouse genome DNA and cDNA
of CKT2 as probe (Figure 2A). A 1.6kb EcoRI fragment
was cloned and sequenced and the CKT2 gene was loca-
lized in BAC number 8 of the mouse genome. The
sequence of 1.6 kbp EcoRI fragment was compared to
CKT2 cDNA nucleotide (Supplementary Figure 2).
Mouse Genome Blast database (WU-BLAST 2.0) and
Celera Genomics Database indicated that CKT2 was an
unknown gene localized to mouse chromosome 16.
Expression of CKT2 inmouse testis
Reverse transcription coupled with PCR ampliﬁcation
(RT–PCR) was performed to determine which mouse
tissue(s) expressed CKT2. RT–PCR was performed on
total mRNA isolated from diﬀerent tissues to amplify
the region encompassing an 880bp fragment of CKT2
from mouse testis-derived cDNA. As shown in
Figure 2B (top panel), an 880bp RT-PCR product corre-
sponding to CKT2 mRNA was found exclusively in
mouse testes. Figure 2B (middle panel) shows b-actin
control for the RT–PCR reactions. In order to conﬁrm
that this RT–PCR fragment corresponded to CKT2,a
Southern blot was performed using a
32P-labeled pCKT2
cDNA fragment excised by EcoRI/XhoI. As shown
in Figure 2B (bottom panel), a strong positive signal for
CKT2 gene was obtained in the testes. These results show
that in the mouse, CKT2 is speciﬁcally expressed in the
testes.
A western blot of mouse testicular lysates using a mouse
monoclonal antibody against CKT2 revealed a protein
of about 30–31kDa, consistent with the size of CKT2
protein as predicted by the ORF of the CKT2 gene
(Figure 2C). These ﬁndings indicate that the cloned
CKT2 cDNA encodes the full-length CKT2 protein.
To further investigate CKT2 expression in the mouse
testes, we performed in situ hybridization on sections of
adult mouse testes, using a
35S-labeled pBCKT2/EcoRI
antisense riboprobe or a negative control
35S-labeled
pBCKT2/XhoI sense Riboprobe. No signal was present
in testis section hybridized with the sense probe
(Figure 3A). Sections of the testes hybridized with
antisense probe showed a CKT2 mRNA signal localized
in the seminiferous tubules, while the signal was absent in
1 MRGKPNPRPGPRLSSTYSVCLECASAIKSQCNHLSGKRDPRCATLFVIPT
51 PESSTDGKVDVKIILILSLPEKPSSTCFQLPMKDSKSENNLEALDDNLDV
101 LEKITQFFPASESDFIQGLKTKRKCLAVSSESKDLSQEPQSIDWLLYVKN
151 SNGIQLETQVQGPSSSSSSSCSSVSSSSSASSIGRPSPPTPWVDPTPVPV
201 SGYVLAKVRSYHRLPPGTS SWLEFIRGSSSDTIKLRQSPPVKAKPVRSHNS
251 KCLKKGKRETSALLRYFQTKFQNEKS
CK2
coiled-coil domain
CK2 CK2
CK2
CK2 CK2
50 100 150 200 250 300
Amino Acid Number
0
0.2
0.2
0.6
0.8
1.0
C
o
i
l
e
d
-
c
o
i
l
 
P
r
o
b
a
b
i
l
i
t
y
A B
Figure 1. (A) CKT2 amino acid sequence corresponding to the CKT2 open reading frame. The sequence contains a coiled-coil domain and six
putative CK2 phosphorylation sites. The numbers on the left refer to amino acid positions (Genbank Accession No. NM_173861). (B) Prediction of a
coiled-coil domain in the CKT2 gene. The x-axis corresponds to the amino acid numbers. The probability of the polypeptide to assume a coiled-coil
conformation is plotted on the y-axis.
Nucleic Acids Research,2009, Vol.37, No. 8 2703the inter-tubular compartment. Higher magniﬁcation
showed a strong signal in the intermediate compartment
of the seminiferous tubules (Figure 3B). A weak signal
was located in the basal compartment containing
spermatogonia and in the adluminal compartment
within condensed spermatids; Figure 3C shows these
three compartments in an H & E stained mouse semini-
ferous tubule. These results indicate that CKT2 was
speciﬁcally expressed in male germ cells undergoing diﬀer-
entiation at stages of spermatocytes and young sperma-
tids. However, expression of CKT2 mRNA cannot be
excluded in Sertoli cells. CKT2 expression in spermatogo-
nia was found to be low, as compared to germ cells at
more advanced stages of spermatogenesis and as shown
by immunohistochemistry (see below).
CKT2 localizes to thenuclei ofspermatids
As shown in Figure 4A, mouse testicular sections immu-
nostained with anti-CKT2 antibody revealed that CKT2
was predominantly expressed in the nuclei of spermatids
(asterisks) and, to a lesser extent, in the nuclei of
some spermatogonia (arrow). Testes incubated with non-
immune IgG revealed absence of staining (Figure 4B).
Sub-cellular localization of CKT2 in male germ cells
was further investigated by immunogold labeling with
anti-CKT2 antibody of mouse testis sections embedded
in Lowicryl followed by electron microscopy. As shown
in Supplementary Figure 3, CKT2 expression varied with
the stage of chromatin condensation. During the initial
steps of chromatin condensation, CKT2 labeling was
weak in the spermatids (Supplementary Figure 3A) but
increased during the intermediate stages of chromatin
condensation (Supplementary Figure 3B). In more
mature spermatids, the labeling decreased in the apical
nuclear region with greater condensed chromatin, as
compared to the less condensed posterior region
(Figure 4C–E and Supplementary Figure 3C and D).
CKT2 was absent in spermatids with fully condensed
chromatin (data not shown). These ﬁndings indicate a
correlation between a high expression of CKT2 and the
step of chromatin condensation in spermatids.
The nuclear localization of CKT2 was conﬁrmed in
HEK293 cells transfected with Flag-CKT2. As shown
in Figure 5, staining of the transfected HEK293 cells
with FITC-labeled anti-Flag antibody revealed that
CKT2 was found in the nuclei, conﬁrming that CKT2 is
a nuclear protein.
CKT2 interacts withthe CK2a’ subunitof CK2
In order to determine whether CKT2 interacts with CK2
subunit(s), we used three experimental approaches: yeast
two-hybrid assay, glutathione S-transferase (GST) pull-
down assay, and co-immunoprecipitation. In the ﬁrst
approach, cDNAs encoding CK2a, CK2a0 or CK2b sub-
unit were each ligated into pGBKT7 vectors using the
yeast two-hybrid technique. cDNAs encoding either the
full length, the N-terminus, or the C-terminus of CKT2
were ligated into pACT2 vectors in order to express each
as a fusion protein with the DNA-binding domain
B A C
B
A
I
Figure 3. In situ hybridization analysis revealed that CKT2 mRNA was expressed by germ cells in mouse testis. Testicular section hybridized with
35S-CKT2 sense probe (A) or antisense probe (B). Diﬀerences in the blue color background between the two ﬁgures are due to diﬀerent magniﬁca-
tions (low in A and high in B) and the color of the silver grain signal was due to adjustment of various ﬁlters of the microscope. Hybridization
signals of CKT2 were observed in the intermediate compartment of seminiferous tubules. (C) A serial section stained by H&E shows the mouse
seminiferous tubule compartments (B: Basal; I: Intermediate; A: Adluminal). Scale bar: 100mm. Data shown are representative of three independent
experiments.
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Figure 2. Expression of CKT2 gene and CKT2 protein. (A) Southern
blot analysis. Mouse BAC genomic DNA (10mg) was digested with
BamHI (lane 1), EcoRI (lane 2), HindIII (lane 3) and XbaI (lane 4).
The fragments were hybridized with a 1.1kb radiolabeled cDNA probe
of CKT2 (nucleotides 242–1342). A 1.6kb fragment was obtained with
EcoRI (arrowhead). The sizes of DNA /HindIII markers are indicated
on the left. (B) Upper panel: RT-PCR of CKT2 transcripts from total
RNA from various mouse tissues. An 880bp PCR product is present
only in mouse testis; Middle panel: RT–PCR of b-actin as control;
bottom panel: Southern blot of various mouse tissues with
32P-labeled
pCKT2 cDNA fragment excised with EcoR1/Xhol conﬁrms that the
RT–PCR product corresponded to the CKT2 gene. Markers (M), brain
(Br), heart (H), lung (Lu), liver (Li), kidney (K), testis (Te), thymus
(Th) and spleen (S). (C) Western blot of mouse testicular lysates with
mouse monoclonal anti-CKT2 antibody. A protein of about 31kDa is
revealed (arrowhead). Amount of protein loaded: lane 1 (30mg), lane 2
(10mg), and lane 3 (5mg). Data shown are representative of three inde-
pendent experiments.
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domain (pACT2) of the yeast Gal4 transcription factor.
The S. cerevisiae strain HA109, which expresses
b-galactosidase activity under the control of a Gal1 pro-
moter upon binding by the Gal4 transcription factor, was
then co-transformed with various combinations of
pGBKT7 and pACT2 constructs. An indication for
interaction between fusion proteins was measured by
b-galactosidase activity in extracts from the various
transformants.
CKT2 was found to strongly interact with CK2a0 with a
b-galactosidase activity of 5.8 0.3 (Table 1). By contrast,
CKT2 minimally interacted with the CK2a subunit, with
b-galactosidase activity that is nearly 6-fold less than seen
with the CKT2–CK2a0 interaction. CKT2 essentially
did not bind to CK2b (Table 1). Since the yeast two-
hybrid system showed that 13 yeast colonies contained
CK2b, it suggested that CKT2 is a true target protein
of CK2a0 since CK2a0 interacts with CK2b. This is also
supported by the observation that clones of CKT2 and
CK2b appeared simultaneously after co- transformation
in S. cerevisiae strain AH109 (data not shown).
To investigate which region of CKT2 binds to CK2a0,
we constructed the full length, N-terminus and C-terminus
portions of cDNA as binding domains. A co-transforma-
tion was performed with CK2a0 as the active domain in
S. cerevisiae strain AH109 for b-galactosidase ﬁlter and
liquid assay. The b-galactosidase activity was >2-fold
greater with the C-terminus region (BD-CKT2 138–276)
than the N-terminus region (BD-CKT2 1–137), and
modestly higher than the full-length BD-CKT2
(Table 2). These data indicate that CK2a0 preferentially
interacts with the C-terminus region of CKT2 but that
there was modest binding to the N-terminus as well.
CKT2binds to CK2a’but notto CK2ain vitro
In a second approach to determine if CK2a0 interacts
directly with CKT2, a GST pull-down assay was per-
formed. Two methods were used. In the ﬁrst method,
CK2a0 or CK2a were translated under the T7 promoter
and labeled with
35S-methionine. Labeled
35S-CK2a0 or
35S-CK2a were then incubated with GST-CKT2 fusion
protein and glutathione-sepharose beads. After washing
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Figure 4. Expression of CKT2 in testicular cells. (A) Immunohis-
tochemistry of testis section with anti-CKT2 antibody; nuclei of
spermatogonia (arrow) and spermatids (asterisks). (B) Testis incubated
with nonimmune IgG antibody. (C) Immuno-gold labeling for CKT2 of
a spermatid at step 13 of diﬀerentiation showing that CKT2 is present
in the nuclei of spermatids undergoing chromatin condensation. As
shown in the magniﬁed views, the labelling is weaker in the more
condensed apical nuclear region (D), as compared to the stronger
labelling in the less condensed posterior nuclear region (E) (see the
labelling pattern of spermatids at diﬀerent steps of diﬀerentiation in
Supplementary Figure 3). Data shown are representative of two inde-
pendent experiments.
Figure 5. CKT2 expression in the nuclei of HEK293 transfected cells.
The epitope Flag was fused to CKT2 gene and subcloned into pcDNA3
expression vector and transfected into mammalian HEK293 cells, as
described in Materials and Methods section. Immunoﬂuorescent stain-
ing of transfected cells with FITC-labeled anti-Flag antibody revealed
that CKT2 was found predominantly in the nuclei.
Table 1. CK2a0 interacts with CKT2 in yeast two-hybrid assay
Construct Growth in plates b-Gal
activity
Filter color
Trp-/Leu- Trp-/Leu-/His-/Aden-
BD-CK2a0 + + 5.8 0.3 Blue
BD-CK2a + + 1.0 0.3 Light blue
BD-CK2b +–  0.05 White
b-galactosidase activities are expressed as the mean of ﬁve experiments
 SD. *P<0.005 compared to BD-CK2a0.
Table 2. CKT2 interacts with CK2a0 in yeast two-hybrid assay
Construct Growth in plates b-Gal
activity
Filter
color
Trp-/Leu- Trp-/Leu-/His-/Aden-
BD-CKT2 + + 5.2 0.3 Blue
BD-CKT2 138-276 + + 6.5 0.3 Blue
BD-CKT2 1-137 + + 2.8 0.3 Blue
b-galactosidase activities are expressed as the mean of ﬁve experiments
  SD.
Nucleic Acids Research,2009, Vol.37, No. 8 2705the beads three times, GST was cleaved from the
glutathione-sepharose beads. The supernatants were
separated by SDS–PAGE and subjected to autoradiog-
raphy. As shown in Figure 6A (lane 1), GST protein
alone did not bind to
35S-labeled CK2a0. However, after
incubating GST-CKT2 with
35S-CK2a0 and electropho-
resis, autoradiography revealed two protein bands
which corresponded to CK2a0 (Figure 6A, lane 2). The
presence of two isoforms of CK2a0 is likely related
to the presence of two methionine start codons during
in vitro translation. The electrophoretic location of
CK2a0 was conﬁrmed by electrophoresing only
35S-CK2a0 (Figure 6A, lane 3). As shown in Figure 6B
(lane 1), GST protein alone did not bind to
35S-labeled
CK2a. In contrast to CK2a0 binding to CKT2, no bands
were detected after incubating the GST-CKT2 fusion
protein with
35S-CK2a (Figure 6B, lane 2). Figure 6B,
lane 3 contains only the labeled
35S-CK2a. These
data conﬁrmed that CKT2 can bind to CK2a0 but not
to CK2a.
In a second method to examine the binding of CKT2 to
CK2a0 and/or CK2a subunits, 10mg of GST or GST-
CKT2 fusion protein were incubated with 50mg of testi-
cular lysates from either wildtype or CK2 0 /  mice (23),
precipitated with glutathione-sepharose beads, and ana-
lyzed by western blot with combined anti-CK2a and
anti-CK2a0 antibodies. As shown in Figure 6C, a western
blot of whole testicular lysates conﬁrmed the presence of
both CK2a and CK2a0 in the wildtype mice (lane 4) and
only CK2a in the CK2 0 /  mice (lane 5). As also shown
in Figure 6C (lane 1), GST protein alone did not bind
CK2a or CK2a0 when GST was incubated with testicular
lysates from the wild-type mice. Despite the fact that
the relative band intensity for CK2a was greater than
for CK2a0 in the testicular lysates from wild-type mice
(lane 4), the band intensity for CK2a was weaker in the
GST-CKT2 pulldown assay following incubation with
testicular lysates from the wild-type mice. This suggests
that the binding of CKT2 to CK2a is signiﬁcantly
weaker than to CK2a0. Importantly, no bands were
observed when testicular lysates from CK2 0 /  mice
were incubated with GST-CKT2 (lane 3). These results
conﬁrm the ﬁndings of the yeast two-hybrid and the bio-
synthetic GST-pull-down assays that CKT2 binds to
CK2a0. In addition, it shows that CKT2 can also interact
with CK2a but only in the presence of CK2a0.
CKT2 binds to CK2a’ endogenously
We previously showed that the CK2a0 subunit of CK2
binds to recombinant CKT2. Using a third approach
to conﬁrm that CK2a0 binds to CKT2 endogenously,
we determined whether CK2a0 co-immunoprecipitated
with CKT2 in testicular lysates. Mice testicular lysates
were incubated with anti-CKT2 antibody as described
in Materials and methods section. As shown in
Figure 7, immunoblot of testicular lysates with anti-
CK2a0 antibody revealed a distinct band with a MW
of  38kDa (lane 1), consistent with CK2a0. Lysates
immunoprecipitated with anti-CKT2 antibody revealed
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Figure 6. In vitro binding between GST-CKT2 protein and CK2a0.( A) Autoradiograph of SDS-PAGE following incubation of GST or GST-CKT2
immobilized on glutathione-sepharose beads with in vitro translated
35S-CK2a0; Lane 1, GST protein alone with
35S-CK2a0; Lane 2, GST-CKT2
fusion protein with
35S-CK2a0; Lane 3, only
35S-CK2a0. Standard protein molecular weight markers (kDa) are on the left. (B) Autoradiograph
of SDS–PAGE following incubation of GST or GST-CKT2 immobilized on glutathione-agarose beads with in vitro translated
35S-CK2a; Lane 1,
GST protein alone with
35S-CK2a; Lane 2, GST-CKT2 fusion protein with
35S-CK2a; Lane 3, only
35S-CK2a. Standard protein molecular weight
markers are on the left. (C) Western blot with anti-CK2a and anti-CK2a0 antibodies. GST protein was incubated with testicular lysates (T.L.) from
wild-type mice (lane 1). GST-CKT2 fusion protein was incubated with T.L. from wild-type mice (lane 2) or CK2 0  /  mice (lane 3). Following
incubation, the samples were immunoprecipitated with glutathione-agarose beads followed by western blot using combined anti-CK2a and
anti-CK2a0 antibodies. Lanes 4 and 5 are T.L. from wild-type and CK2 0  /  mice, respectively, also immunoblotted with both anti-CK2a and
anti-CK2a0. Data shown are representative of three independent experiments.
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Figure 7. CK2a0 binds to CKT2 endogenously. Testicular lysates (T.L.)
were immunoprecipitated with an anti-CKT2 antibody or a non-
immune antibody, followed by separation of the proteins by SDS–
PAGE. The proteins were transferred onto nitrocellulose membranes
and immunoblotted with anti-CK2a0 antibody. Lane 1, T.L.; lane 2,
immunoprecipitation of T.L. with anti-CKT2 antibody; lane 3, immu-
noprecipitation with nonimmune IgG.
2706 Nucleic Acids Research, 2009, Vol. 37,No. 8that CK2a0 co-immunoprecipitated with CKT2 (lane 2)
whereas CK2a0 was not detected in lysates immunopre-
cipitated with a nonimmune IgG (lane 3).
CK2 phosphorylates CKT2 invitro and in vivo
Based on the consensus sequence (S/T)XX(D/E) that
is phosphorylated by CK2, CKT2 contains six potential
CK2-mediated phosphorylation sites at positions
54SSTD,
68SLPE
85SKSE,
111SESD,
219SWLE and
227SSSD
(Figure 1). Hence, we further substantiated the functional
signiﬁcance of CKT2-CK2 interaction by examining
the phosphorylation of CKT2 by CK2 using three diﬀer-
ent approaches. First, to determine which subunit(s)
of CK2 could phosphorylate CKT2, we incubated puriﬁed
recombinant CKT2 with recombinant CK2a0b, CK2ab,
CK2a0, CK2a, CK2b or CK2a0ab in an in vitro phosphor-
ylation assay. As can be seen in Figure 8A (upper panel),
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Figure 8. CK2 phosphorylates CKT2 in vitro.( A) The ability of diﬀerent subunit combinations of CK2 to phosphorylate CKT2 was examined in
in vitro kinase assays in which CKT2 was incubated with recombinant CK2a0b, CK2ab, CK2a0, CK2a, CK2b or CK2a0ab in the presence of 5mCi
[g-
32P]-ATP. Aliquots were blotted to a membrane, and the amount of
32P incorporated into CKT2 was quantiﬁed with a PhosphoImager with the
greatest phosphorylation band set at 100% (arbitrary units). A Coomassie stain of GST-CKT2 recombinant protein is shown in the top panel, the
autoradiography in the bottom panel. Quantitation of CKT2 phosphorylation: Lane 1 (100%), Lane 2 (2%), Lane 3 (3%), Lane 4 (3%), Lane 5
(4%), Lane 6 (93%). (B) Phosphorylation of CKT2 by CK2 in the presence of a inhibitory peptide of CK2 or a noninhibitory peptide. GST (lane 1)
or GST-full length CKT2 fusion protein (lanes 2–5) were incubated with recombinant CK2 (30ng) in the presence of 5mCi [g-
32P]-ATP as indicated.
Some samples containing GST-full length CKT2 fusion protein and recombinant CK2 were also incubated in the presence of a noninhibitory peptide
of CK2 (RETSALLRYFQTKFQNEKS) that does not contain a phosphorylation site (lane 3) or a competitive inhibitory peptide of CK2
(ETERRREEETEEE or DSDRRRDDDSDDD) that contains a phosphorylation site (lanes 4 and 5). The samples were subjected to SDS–PAGE
and revealed by Coomasie (top panel) or autoradiography (bottom panel). Standard protein molecular weight markers are on the left. Quantitation
of CKT2 phosphorylation: Lane 1 (5%), Lane 2 (100%), Lane 3 (88%), Lane 4 (15%), Lane 5 (5%). (C) Heparin inhibited CKT2 phosphorylation
by CK2. Heparin at concentrations of 0.5–20mg/ml was added to the in vitro phosphorylation assay between GST-CKT2 and recombinant CK2a0b.
Quantitation of CKT2 phosphorylation: Lane 1 (100%), Lane 2 (100%), Lane 3 (25%), Lane 4 (12%), Lane 5 (7%). (D) CKT2 phosphorylation
by testicular lysates (T.L.) of wild-type or CK2 0 /  mice. GST was incubated with T.L. from wild-type mice and subjected to ex vivo phosphor-
ylation in the presence of [g-
32P]-ATP (lane 1). GST-C-terminus CKT2 (lanes 2 and 3) or GST-full length CKT2 (lanes 4 and 5) fusion proteins were
subjected to ex vivo phosphorylation by T.L. from either wild-type (lanes 2 and 4) or CK2 0  /  (lanes 3 and 5) mice. The samples were subjected to
SDS–PAGE and revealed by Coomassie (top panel) or autoradiography (bottom panel). Quantitation of C-terminus-CKT2 phosphorylation: Lane 2
(100%), Lane 3 (22%). Quantitation of full length-CKT2 phosphorylation: Lane 4 (100%), Lane 5 (10%). Data shown are representative of three
independent experiments.
Nucleic Acids Research,2009, Vol.37, No. 8 2707a Coomassie stain showed equal loading of GST-CKT2
fusion protein. Incubation of CKT2 with CK2a0ab served
as a positive control and showed robust phosphorylation
of CKT2 (Figure 8A, lower panel, lane 6). As also shown,
neither CK2ab, CK2a0, CK2a nor CK2b alone were cap-
able of phosphorylating CKT2. However, CKT2-GST
was phosphorylated by recombinant CK2a0b (lane 1),
indicating that the regulatory subunit CK2b was required
for CK2a0 kinase activity.
Second, in vitro kinase assays were also performed
with recombinant CKT2 and CK2 kinase in the presence
of a competitive inhibitory peptide of CK2 that contains a
phosphorylation site for CK2. A noninhibitory peptide
without a CK2 phosphorylation site served as a control.
A Coomassie stain showed equal loading of GST-CKT2
among experimental conditions (Figure 8B, upper panel).
Whereas the control peptide did not signiﬁcantly inhibited
such phosphorylation (Figure 8B, bottom panel, lane 3),
the CK2 inhibitory peptide strongly inhibited CK2
phosphorylation of CKT2 (Figure 8B, bottom panel,
lanes 4 and 5). To conﬁrm these results, in vitro phos-
phorylation of CKT2 with recombinant CK2 was per-
formed in the presence of heparin, a polyanion known
to inhibit CK2 activity (27). Shown in Figure 8C (top
panel) is a Coomassie stain showing equal loading
of GST-CKT2 fusion protein. Heparin inhibited CK2
phosphorylation of GST-CKT2 in a dose-dependent
fashion, with  90% inhibition with 5mg/ml of heparin
and total inhibition with 10mg/ml of heparin (Figure 8C,
bottom panel).
Third, since the activity of CK2 is high in testes, we
examined whether GST-CKT2 full length or GST-
CKT2-C-terminus could be phosphorylated by testicular
lysates from wildtype and CK2 0 /  mice in an ex vivo
approach (21). Thus, mouse testicular lysates were used
as a kinase source for the phosphorylation reactions.
As shown in Figure 8D, GST protein alone was not
phosphorylated by testicular lysates from the wild-type
mice. As also demonstrated, both GST-CKT2 C-terminus
and GST-CKT2 full length were robustly phosphorylated
by testicular lysates from wild-type mice (lanes 2 and 4,
respectively). These results indicate that CKT2 is
phosphorylated by native cellular CK2 and that CK2a0
is the essential subunit for CK2 phosphorylation activity.
Although there was minimal phosphorylation of the
substrates by the testicular lystates from the CK2 0 / 
mice (lanes 3 and 5, respectively), it suggests that
kinases other than CK2a is responsible since the in vitro
data with recombinant proteins showed that CKT2
was not phosphorylated by either CK2a or CK2ab
(Figure 8A).
To determine whether endogenous CKT2 can be phos-
phorylated by CK2, CKT2 was co-immunoprecipitated
with CK2a0 from testicular lysates using anti-CK2a0
antibody and protein A-sepharose beads. After washing
the beads, an in vitro CK2 kinase assay was performed
by adding to the immunoprecipitate mixture [g-
32P]-ATP
and CK2 casein (see Materials and Methods section). As
shown in Figure 9A, immunoprecipitated CKT2 was
phosphorylated by CK2 (lane 1). In contrast, testicular
lysates incubated with nonimmune IgG showed no phos-
phorylation by CK2 (lane 2).
To determine whether CKT2 can be phosphorylated
endogenously by CK2 in vivo, we metabolically labeled
CKT2-transfected HEK293 cells with [
32P]-orthophos-
phate, followed by immunoprecipitation with anti-CKT2
antibody. In an analogous fashion, Li and co-workers (28)
previously showed that HEK293 cells contain CK2 and
have used this cell line to show that CK2 phosphorylates
the transfected ARC protein in vivo. The immunoprecipi-
tate was separated by SDS–PAGE and subjected to auto-
radiography. As shown in Figure 9B, HEK293 cells
transfected with the empty vector did not reveal a
phosphorylated band consistent in size with CKT2.
However, in cells transfected with the plasmid that
encodes for CKT2, phosphorylated CKT2 was detected
in the immunoprecipitate. In the presence of a CK2 inhib-
itor (DRB), there was signiﬁcant decrease in the cellular
phosphorylation of CKT2. Immunoblotting of the same
nitrocellulose membrane with anti-CKT2 revealed equal
amounts of total CKT2. We conclude from these studies
that CKT2 can be phosphorylated by CK2 both in
an in vitro kinase assay as well as endogenously as detected
by metabolic labeling.
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Figure 9. Endogeous CKT2 is phosporylated by CK2 in vitro and
in vivo.( A) CKT2 was co-immunoprecipitated with CK2a0 from
testicular lysates with anti-CK2a0 antibody (Lane 1). As a control,
testicular lysates was also incubated with non-immune IgG (Lane 2),
followed by an in vitro kinase assay using [g-
32P]-ATP and CK2. Data
shown are representative of three independent experiments. (B) CKT2
is phosphorylated by endogenous CK2 in vivo. HEK293 cells were
transfected with an empty vector or the CKT2 plasmid (pcDNA3-
CKT2). After transfection and 24 hrs of culture, the cells were
incubated with 1mCi/mL [
32P]-orthophosphate with or without a
CK2 inhibitor DRB (5,6-dichloro-1-b-D-ribofuranosyl-benzimidazole)
for 6 h. Following cell lysis and centrifugation, the supernatant was
immunoprecipitated with anti-CKT2 antibody. The immunoprecipitate
was separated by SDS-PAGE, transferred onto a nitrocellulose mem-
brane, and subjected to autoradiography. The membrane was then
immunoblotted with anti-CKT2 antibody to determine equal loading
of protein. Data shown are representative of three independent
experiments.
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CK2 is an intracellular signalling molecule known to
phosphorylate many substrates (6). Indeed, it has been
proposed that the number of proteins phosphorylated
by CK2 may be much more numerous than those identi-
ﬁed to date (6) and that CK2 alone may be responsible
for the generation of a relatively large proportion
(10–20%) of the eukaryotic phosphoproteome (10).
We identiﬁed a novel gene CKT2 whose product CKT2
is a target for CK2. RT-PCR and ISH studies showed that
expression of CKT2 is testis-speciﬁc. Furthermore, immu-
nohistochemistry and immunocytochemistry revealed
that CKT2 is localized to the nuclei of male germ cells.
Although CKT2 does not appear to have a nuclear local-
ization signal (NLS) peptide, this sequence is not
known to be required for proteins <45kDa because they
are able to passively diﬀuse through nuclear pore com-
plexes (29).
Survey of the CKT2 sequence showed that it contains a
coiled-coil domain and six putative CK2 phosphorylation
sites, one of which is located in the coiled-coil domain.
Phosphorylation of a coiled-coil assembly may serve to
regulate the conformation of the parent protein (30).
CKT2 was found to be phosporylated by recombinant
puriﬁed CK2. GST pull-down and yeast two-hybrid
assays showed that CKT2 binds to the CK2a0 subunit.
Furthermore, in testicular lysates immunoprecipitated
for CKT2, CK2a0 was co-immunoprecipitated, indicating
that CK2a0 binds to CKT2 endogenously. In addition,
we showed that endogenous CK2a0 immunoprecipitated
from testicular lysates can phosphorylate CKT2. We
also found that recombinant CKT2 is phosphorylated
by CK2a0 but that the regulatory subunit CK2b was
required for the kinase activity of CK2a0. As shown
in Figure 1A, there are six amino acid residues on
CKT2 that are potential sites of phosphorylation by
CK2. Although phosphorylation of one or more of these
sites is likely necessary for full CKT2 function, future
studies involving site-directed mutagenesis of each or
more of these residues would be required to determine
the consequences of their phosphorylation in regulating
spermatid chromatin condensation. Furthermore, it is
interesting to speculate that the serine-rich domain from
amino acid positions 164–182 of CKT2 may be phos-
phorylated by an unknown kinase, creating an acidic
region that may render CKT2 to be more susceptible to
phosphorylation by CK2 (Figure 1A).
A study of the spatio-temporal dynamics of CK2 in
living cells has revealed that both CK2a and CK2a0 are
located mostly in nuclei (31). Immuno-electron micros-
copy revealed that CKT2 is present in spermatid nuclei
undergoing chromatin condensation, consistent with
previous ﬁndings in yeasts that CK2-induced gene
expression are those that encode chromatin remodeling
proteins (32).
CK2a0 is highly expressed in testis (33) and appears
to have an important role in survival and nuclear integrity
of male germ cells (23,24). Genetic disruption of CK2 0
results in extensive nuclear alterations and apoptosis
of diﬀerentiating male germ cells. Such morphologic
changes in male germ cell diﬀerentiation include large
nuclear envelope protusions and chromatin degeneration
(24). Our observation that CKT2 is highly expressed at
a speciﬁc step of spermatid chromatin condensation
suggests that CKT2 and CK2a0 are involved in chromatin
regulation during its remodelling. In spermatids undergo-
ing condensation, somatic histones are replaced by lysine-
rich transition proteins and, in turn, transition proteins
are replaced by relatively arginine- and cysteine-rich
protamines (34,35), processes that indicate complex pro-
tein–DNA interactions (36).
The TSPY testis-speciﬁc protein has already been found
to play a role in the development of testicular cancer
and prostate cancer. Interestingly, TSPY is known to be
involved in chromatin remodelling and to be dependent
on CK2 phosphorylation for its entrance into nuclei (37).
The unique testicular phenotype of CK2 0 /  mice raises
the question of whether CK2a0 could contribute to the
pathogenesis of male germ cell tumors. Current evidence
indicate that elevated expressions of CK2a0 are found in
a number of metastatic tumors (38). Nuclear localization
of CK2a is associated with a poorer prognosis in human
prostate cancer (14). The anti-apoptotic function of
CK2 may contribute to its ability to participate in trans-
formation and tumorigenesis. CK2 activates histone dea-
cetylase in hypoxia-associated tumors; in addition, upon
hypoxic treatment, both CK2a and CK2a0 shuttle into
the nucleus where histone deacetylases are localized (39).
Administration of a peptide that targets the acidic phos-
phorylation domain for CK2 substrates has an anti-tumor
eﬀect in the mouse (17). Furthermore, strategies to inhibit
CK2 have been ongoing in preclinical trials (16). Although
CKT2 shares some homology with the oncogene product
c-Myc (Supplementary Figure 1), the relatively sparse
expression of CKT2 in spermatogonia would argue
against its role in the nuclear alterations seen in the sper-
matogonia of CK2 0 /  mice and in testicular cancers.
In summary, this study identiﬁed CKT2 as the ﬁrst
known target for CK2a0 during spermatogenesis. CKT2
expression was found to parallel chromatin remodelling,
suggesting important nuclear functions of CK2a0 and
CKT2 in germ cells. CK2 0 /  mice and future develop-
ment of a CKT2 /  mice will be important models
to extend these studies. Future work needs to also address
whether CKT2 is a CK2a0 target in premeiotic male
germ cells and various germ cell tumors. Such elucidation
would be invaluable to the emerging work of generating
male germ cells from embryonic stem cells (40), given
the known similarities between the primordial germ cells
and embryonic stem cells (41,42).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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